Stock Market Manager Weekly Update: March 4th, 2021

Weekly UpdateMarch 4, 2021

Black Swan Connection Newsletter Signup

Breaking News

What makes Warren Buffett special…

Aside from being one of the most successful investors of all time and making a lot of people rich in the process….

Yahoo Finance 2-27-21

Warren Buffett is still at it. Having received his COVID-19 vaccine recently, (two Pfizer shots according to Bloomberg), Buffett, 90, isn’t slowing down much (at least mentally) and seems poised to lead his company into the post-pandemic world. ‌ In his highly-anticipated annual letter to shareholders, released at 8 a.m. ET on the dot this morning, Warren Buffett, one of the world’s richest people—equally blessed with wit and sagacity (more on that in a bit)—waxed on about the virtues (and blemishes) of the conglomerate he controls, Berkshire Hathaway, the nation’s sixth largest company.   Read Complete Report

3-3- 2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)

Antibe Therapeutics to Present at Upcoming Virtual Investor Conferences

Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop next-generation safer therapies to address inflammation arising from a wide range of medical conditions, today announced its participation in the following investor conferences in March:

H.C. Wainwright Global Life Sciences Conference on Tuesday, March 9, 2021 at 7:00 am (Eastern Time) a pre-recorded company presentation will become available for on-demand viewing.
Roth Capital Partners Annual Conference, Live fireside chat on Monday, March 15, 2021, at 9:00 am (Eastern Time).
Oppenheimer & Co. 31st Annual Healthcare Conference, Company presentation on Tuesday, March 16, 2021 at 9:20 am (Eastern Time).
Maxim Group Emerging Growth Virtual Conference on Wednesday, March 17, 2021 at 10:00 am (Eastern Time) a pre-recorded company presentation will become available for on-demand viewing.
Read Complete Report


2-25-21 Perpetual Industries, Inc. (OTC: PRPI)

Video Update with Perpetual and Worldwide Auctioneers following the recent acquisition of Worldwide Auctioneers by Perpetual Industries, Inc.

Check out the latest video with CEO Brent Bedford in this casual fire-side chat with managing partners John Kruse and Rod Egan of Worldwide Auctioneers. They discuss the recent acquisition and share a glimpse into what the future might look like for Perpetual’s new wholly-owned subsidiary.

Watch Complete Video

2-23-21 Can B Corp. (OTCQB: CANB)

Can B Corp. Executes Definitive Agreement to Acquire the Assets of Imbibe Health Solutions
Business Entrepreneur and Advertising and Marketing Expert Walter Hoelzel to Join Can B

HICKSVILLE, NY / ACCESSWIRE / February 23, 2021 / Can B Corp. (OTCQB:CANB) (“Can B” or the “Company”), a diversified health and wellness company, is pleased to announce it has signed a definitive agreement to acquire the assets of Imbibe Health Solutions LLC (“Imbibe”), a developer and marketer of CBD and related products.

Imbibe has developed several CBD health and wellness products including topical salves, bath soaks, massage oils, and energy and dietary supplements. CANB will be putting Imbibe into one of its current inactive wholly-owned subsidiaries and will be renaming that subsidiary to reflect the products and culture that comes with the Imbibe acquisition.
Read Complete Report

2-17-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)

Antibe Therapeutics Announces C$35 Million Bought Deal Public Offering

TORONTO, Feb. 17, 2021 /CNW/ – Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE) today announced that it has entered into an agreement with Canaccord Genuity Corp. on behalf of a syndicate of underwriters (together, the “Underwriters”) and pursuant to which the Underwriters have agreed to purchase, on a bought deal basis, 5,850,000 units (the “Offered Securities”) in the capital of the Company at a price of C$6.00 per Offered Security (the “Offering Price”) for aggregate gross proceeds to the Company of C$35,100,000 (the “Offering”).
Read Complete Report

1-11-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)

Antibe Therapeutics Announces Strategic Licensing Deal in China With Nuance Pharma
– US$100 million in milestone payments including US$20 million upfront, as well as a double-digit royalty

– Nuance’s business model, commercial acumen and collaborative approach considered an ideal fit for Antibe

Antibe Therapeutics Inc. (TSX: ATE, OTCQB: ATBPF) today announced that it has licensed otenaproxesul to Nuance Pharma for commercialization in the Greater China region. Nuance is a biopharmaceutical company focused on licensing, developing and commercializing globally innovative therapies to address critical unmet medical needs in China and other Asia Pacific markets. Founded by Mark Lotter, who built the AstraZeneca commercial franchise in China, and led by executives with extensive multinational pharma experience, Nuance focuses on identifying and in-licensing therapies that have achieved best-in-class, human proof-of-concept status.
Read Complete Report

2-8-21 Greenridge Global Securities Issues Update

Guangdong Land Holdings, Ltd. [HKSE: 0124]
Maintaining Buy Rating and Target HK$5.00

HK$1.0 Billion Loan Facility Announced

HK$1.0 Billion Loan Facility.  Last week, GDL announced it entered into a term facility with an undisclosed bank for HK$1.0 billion.  The announcement of such a facility has been expected as the Company continues to add to its property portfolio.  We expect the funds will be used for development and operating expenses in between cash receipts from the pre-sale and sale of completed properties. 

Acquisitions Completed.  On January 13, the Jiangmen Acquisition was completed and on January 18, the Huizhou Acquisition was completed.  Please see our November 2, 2020 and December 16, 2020 reports for additional details.

Model Update.  We made no changes to our model as we had assumed bank financing and the completion of both acquisitions.

Maintaining Rating & Target.  The news since our last update had largely been expected.  With no changes to our model we are reiterating our Buy rating and HK$5.00 target price on Guangdong Land Holdings.  Our target price is based on our DCF model that covers GDL’s entire project portfolio, discounted at 6.5%.  
Read Complete Report

1-13-2021 SRAX, Inc. Nasdaq SRAX
SRAX to Host and Present at the B. Riley Securities 2021 Vision Day on the Sequire Virtual Events Platform

SRAX, Inc. (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, announced that it will be hosting the B. Riley Securities 2021 Vision Day via its Sequire Virtual Events platform, and presenting at the event as one of B. Riley’s top picks for 2021.

Sequire’s Virtual Events platform, allowing companies to virtually present to institutional and retail investors, is the most recent addition to the suite of products on the Sequire platform. “We recognize that virtual events are here to stay, and for public companies, the platform offers everything issuers need to host their meetings with maximum exposure,” said Christopher Miglino, Founder and CEO of SRAX.
Read Complete Report

1-11-2021 Antibe Therapeutics Inc. OTC ATBF (TSXV:ATE)

Antibe Therapeutics Provides 2021 Corporate Update
– Large market partnering program now underway –

– Limited COVID-19 impact: Phase III program slated to start in second half of 2021 –

– U.S. institutional outreach expanding –

Antibe Therapeutics Inc.:

To our shareholders,

As we build on last year’s significant clinical and capital markets achievements and enter the homestretch in the strategic monetization of otenaproxesul, we want to update you on our progress and plans. We are particularly gratified by the recent uptick in interest by both global and regional potential partners, supporting otenaproxesul’s compelling value proposition and revenue opportunity. We are also encouraged by the response to our U.S. institutional outreach, further validating our strategy for unlocking the value of our assets as we move toward a potential listing on a senior U.S. exchange.
Read Complete Release

1-6-21 Greenridge Global Securities Issues Update

Apollo Future Mobility Group, Ltd.[HKSE: 0860]

Buy Rating-Target HK$ 1.50

Ideenion Acquisition EGM set

Ideenion Acquisition Update.  AMFG released the Circular for the Ideenion acquisition and announced it is holding an Extraordinary General Meeting on January 29 at 11am in Science Park to vote on the acquisition.  A few key notes from the Circular include that prior to COVID, Ideenion was generating roughly HK$157.6 million in Revenue and HK$37.9 million in Net Profit per year.  Despite being impacted by COVID, it has a pipeline of projects worth roughly €24,450,000 (HK$233,000,000), as well as being in final negotiations with an emerging market client for a fuel cell vehicle and an EV setup with a total project value of €49,000,000 (HK$467,000,000), which gives the vendors confidence in the profit targets being reached for the contingent cash and share issuances.  The independent valuer found a current valuation of €22,000,000.  AMFG is paying €15,000,000 in cash at closing, plus another €1,400,000 in cash and €5,600,000 in shares annually upon meeting profit targets in each of 2021, 2022 and 2023.  All of the cash in Ideenion will be paid out to the Vendors prior to closing with the exception of €1,500,000.  We again note, the potential share issuance is based on Ideenion reaching profit milestones over a three year period with shares being issued at the higher of HK$0.52 or the three-month daily average.  

H2:20 Results.  AMFG reported second half 2020 results (ending September 30) with Revenue of HK$100.8 million, down significantly due to the impact of COVID.  No Apollo IE hypercars were delivered in the period, although one was delivered prior to the end of the calendar year.  Auto engineering services Revenue was just HK$2.6 million as many projects were put on hold.  All of the legacy businesses were hit hard by COVID, as well as Property Investment due to Shenyang expropriating property that the Company owned, which resulted in Other Gains, Net of HK$255.9 million and HK$281.2 million of Land Appreciation Tax in the period; AMFG turned a profit on the building as it had previously been marked up.  Net Loss for the period was HK$141.8 million, or HK$1.98 cents per share.

Model Update.  The model continues to be subject to significant fluctuations due to COVID, however it will get a bit of stability with the closing of the Ideenion acquisition and the world creeping back to normalcy with global vaccine distribution underway.  One Apollo IE was delivered before the end of calendar Q4, marking the third such delivery; two were delivered prior to the completion of the acquisition.  We expect a total of four to six IE’s to be delivered over the course of fiscal 2021, with the remainder falling in fiscal 2022.  The launch of the next Apollo model has been pushed back, and will now be launched later this year.  The DeTomaso P72 has been delayed as well, with deliveries now expected in 2022, however AMFG should begin receiving its license fee on each car produced starting later this year.  We continue to expect the auto products and services business to grow quickly as the world exits COVID and ramp significantly starting in 2022 as a number of the previously discussed products roll out to market.  As a result of these changes, our estimated Revenue and Net Profit numbers for fiscal 2021 and 2022 have contracted.

Retirement of Non-Executive Director.  On December 30, Co-Chairman Zhang Jinbing notified the Board he would not seek re-election to the Board due to his other business commitments.  Mr. Zhang was previously Chairman prior to the change in direction of AMFG in late 2016.

Maintaining Rating & Target.  Getting the Ideenion deal done is an important step for AMFG as it broadens the Company’s reach and tier one customer base.  We continue to believe AMFG is ideally positioned for the changing auto industry with its engineering capabilities and product offerings.  As such, we are reiterating our Buy rating and HK$1.50 target price on Apollo Future Mobility Group.  Our target price is based on a P/E multiple of 25 times our fiscal 2022 Diluted EPS estimate of HK$5.64 cents. 
Read Complete Report


Alternative Investments

Secondary Markets Heating Up for Commercial Investors

By Jennifer Quinn 3-3-21  Florida Realtor Association

Florida Realtors economist: Investors are following renters into the suburban spillover markets. Strong demographics, population growth and an expected recovery in hospitality pulled the Tampa- St. Pete, Miami and Orlando markets into the top 20.
Click Here

If you want to learn more about how to take advantage of opportunities created by the Covid crisis

Message me on Linkedin
https://www.linkedin.com/in/carldilley/

Please subscribe to our newsletter to get ongoing Real Estate and Alternative Investing updates:
Black Swan Connection Newsletter Signup

March 3, 2021 COMPANY QUOTES, LISTINGS RESEARCH AND NEWS   Antibe Therapeutics, Inc (ATBPF)  Profile 11/11/2018 News
AzuerRx Biopharma, Inc. (AZRX) Profile 7/11/2019 News
Can B Corp (CANB) Profile News
Cavitation Technologies, Inc. (CVAT) Profile 8/22/2019 News
Endurance Exploration Group, Ltd (EXPL)  Profile   03-26/19 News
Guangdong Land Holdings Limited (124) HK   Profile 6/6/2019 News
H-Source Holdings, Ltd (HSCHF)   Profile 4/9/2019 News
Summit Wireless Technologies, Inc.   06/04/19
Social Reality, Inc. (SRAX) Profile    02/05/19 News
Apollo Future Mobility Ltd. (HK 0860) Profile 2/23/2020 News


February 25, 2021

ValuEngine Weekly Report

By: Paul Henneman
02/19/2021 ValuEngine Market Update, stock pick

ValuEngine is asked many times every day what our outlook for the market is for the next few months.  We always answer with uncertainty, as that is the nature of the markets these days. We are “generally positive” about the markets and recovery once we put Covid in the rear view mirror. But we are cautious that small things can upset this track. Stay invested. Diversify between riskier investments that could really benefit as the economy recovers, and safer investments to reduce losses if the train comes off the tracks.

 Summary of VE Stock Universe Stocks Undervalued 35.13% Stocks Overvalued 64.87% Stocks Undervalued by 20% 13.75% Stocks Overvalued by 20% 38.52%

Read Complete Report

To subscribe to our bulletins and receive content whenever it is published, subscribe at our blog HERE

Want to learn more about ValuEngine? Our methods? Our history? 
Check out our video presentation HERE

SMM Research Partners

Black Swan Research Coverage and Subscription Service
Click Here>>

Event Calendar Updates

Not Surprisingly most conference events are cancelled or postponed-

LD Micro Main Event (XIII)

LD Micro was a great success.

You can listen to the recorded presentations here.

See the Press Release

Rocky Mountain Microcap Conference

From Dave Lavigne-Trickle Research

A few weeks ago we completed Rocky Mountain Microcap Conference VI.  Replays of all the presentations are now available on the conference site at the following URL/page if you would like to view them:

http://rockymtmicro.com/rmmc-conference-vi-presenters-2/

The page includes a table that will take you to each presenting  company’s website,  their Yahoo page, a replay of the virtual presentation and a copy of their conference powerpoint presentation.   Also, for those presenting companies that are Trickle coverage companies, we have provided a link that will take you to that research at www.trickleresearch.com  as well.   Also, we will have research updates on most of these (as well as other coverage names) shortly.

Those companies include:

  • OncoSec Medical Incorporated  (ONCS)
  • SRAX  (SRAX)
  • Summit Wireless Technologies, Inc. (WISA)
  • Texas Mineral Resources Corp.  (TMRC)
  • Vext Science, Inc. (VEXT)  
  • Assure Holding Inc. (ARHH) (you will need a paid Trickle subscription to access this research)
  • If You Can – If You Can is a private company, but the conference site includes a profile on the Company that we would encourage you to take a look at.  

Dave Lavigne – Senior Analyst/Manager
Trickle Research LLC
720-394-1019

Visit our homepage for up to the minute Financial News, Quotes and our Latest Black Swan Connection Newsletter

Stock Market Manager Homepage

SMM Distribution Update

Distribution (Reach)

SMM Global Twitter Acct     (Impressions last 30 days)          520

SMM Global Facebook Page  (Reach last-30 days)               6,462

SMM Linkedin Pages                 (contacts)                          1,100

SMM Youtube Channel            (followers)                                 6 

SMM Instagram Page  *          (followers)                               11

Direct Email     *                                                          249,000

Total                                                                           256,460

 Black Swan Connection Newsletter Signup

ABOUT US

Check Also

Stock Market Manager Weekly Update: October 22nd, 2021

Weekly Update: October 21, 2021 Black Swan Connection Newsletter Signup Breaking News Death and taxes… Oh …